The federal Food and Drug Administration has granted emergency use authorization of Paxlovid (nirmatrelvir plus ritonavir), the first antiviral pill for the treatment of COVID-19.
The December 22 authorization comes just in time, as the coronavirus Omicron variant is spreading rapidly throughout the United States, but supplies will initially be limited. "This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and [it] promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19," Dr.
Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, stated in a news release. Paxlovid, from Pfizer, is
Meaws.com provides you with the latest lgbt news worldwide. Gossips, photos and videos, exclusive interviews, breaking news from the rainbow world of queer people are waiting for you here. So, stay tuned and get to know who, where, when and with whom in the world of lgbt, happy and proud people. Are you eager to know first!? Then just follow us every day and we will offer you more and more!
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
©2022. All rights reserved.